Impact of Mounjaro on Diabetes and Obesity in Dubai

ein Foto hinzugefügt Health

2024-11-01 18:30:19 -

The introduction of Mounjaro Dubai healthcare sector has marked a significant advancement in the treatment of Type 2 diabetes and obesity, two of the most prevalent health challenges in the region. Developed by pharmaceutical giant Eli Lilly, Mounjaro (also known as Tirzepatide) is an injectable medication that targets two hormonal pathways involved in appetite and glucose regulation. By...

0 Kommentare 0 Anteile 60 Ansichten 0 Vorschau